Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  JACC: Cardiovascular Interventions

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jcin.2012.05.002PMID 22814775
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary Intervention: The Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV)

  2012cited by this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cited by this paper
• Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis.

  2011cited by this paper
• Randomized Comparison of Everolimus-Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery Disease in Patients With Diabetes Mellitus (ESSENCE-DIABETES): Results From the ESSENCE-DIABETES Trial

  2011cited by this paper
• Incidence, predictors, treatment, and long-term prognosis of patients with restenosis after drug-eluting stent implantation for unprotected left main coronary artery disease.

  2011cited by this paper
• Randomized trial of stents versus bypass surgery for left main coronary artery disease.

  2011cited by this paper
• Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data.

  2011cited by this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cited by this paper
• Guidelines on myocardial revascularization.

  2010cited by this paper
• Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial

  2010cited by this paper
• Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial.

  2010cited by this paper
• Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis.

  2010cited by this paper
• Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.

  2010cited by this paper
• Stent thrombosis.

  2010cited by this paper
• 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.

  2010cited by this paper
• Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.

  2010cited by this paper
• A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis.

  2009cited by this paper
• Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgi

  2009cited by this paper
• Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.

  2009cited by this paper
• Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization.

  2008cited by this paper
• A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease.

  2008cited by this paper
• A novel dedicated quantitative coronary analysis methodology for bifurcation lesions.

  2008cited by this paper
• Stents versus coronary-artery bypass grafting for left main coronary artery disease.

  2008cited by this paper
• Short- and Long-Term Clinical Outcome After Drug-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease: Insights From the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital Registries (RESEARCH and T-SEARCH)

  2005cited by this paper
• Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.

  1999cited by this paper
• Approximate case influence for the proportional hazards regression model with censored data.

  1984cited by this paper
• Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I

  year unknowncited by this paper

• Stenting strategy and imaging use in left main percutaneous coronary intervention: insights from a 15-year registry

  2025cites this paper
• Management of failed stenting of the unprotected left main coronary artery

  2023cites this paper
• Clinical outcomes of different revascularization approaches for patients with multi-vessel coronary artery disease: A network meta-analysis

  2023cites this paper
• Past, Present, and Future of Left Main Coronary Artery PCI

  2023cites this paper
• Percutaneous Coronary Intervention for Left Main Coronary Artery Disease

  2022cites this paper
• Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial.

  2022cites this paper
• Unprotected Left Main Revascularization in the Setting of Non-Coronary Atherosclerosis: Gulf Left Main Registry.

  2022cites this paper
• A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study.

  2022cites this paper
• A predictive model involving serum uric acid, C-reactive protein, diabetes, hypercholesteremia, multiple lesions for restenosis risk in everolimus-eluting stent-treated coronary heart disease patients

  2022cites this paper
• SHORT TERM AND LONG-TERM OUTCOMES OF LEFT MAIN PCI AT AFIC-NIHD

  2021cites this paper
• Clinical outcomes of double stent strategy for unprotected left main distal bifurcation lesions using current generation drug eluting stent comparing to early generation drug eluting stent; The Milan and New Tokyo (MITO) registry

  2020cites this paper
• Is left main percutaneous coronary intervention justified in the presence of concomitant complex coronary artery disease – immediate and remote results – single Bulgarian center experience

  2020cites this paper
• Impacts of CYP2C19 Polymorphism and Clopidogrel Dosing on in-Stent Restenosis: A Retrospective Cohort Study in Chinese Patients

  2020cites this paper
• Impacts of CYP2C19 Polymorphism and Clopidogrel Dosing on in-Stent Restenosis: A Retrospective Cohort Study in Chinese Patients

  2020cites this paper
• Crush is superior to Culotte in two-stent strategy for treatment of left main coronary artery bifurcations: A systematic review and meta-analysis.

  2020cites this paper
• Five-year outcomes comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in patients with left main coronary artery disease: A systematic review and meta-analysis.

  2020cites this paper
• Surgical Turndown: "What's in a Name?" for Patients Deemed Ineligible for Surgical Revascularization.

  2019cites this paper
• Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting for the Treatment of Left Main Coronary Artery Disease

  2019cites this paper
• New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry.

  2019cites this paper
• Minimally invasive surgical approaches to left main and left anterior descending coronary artery revascularization are superior compared to first- and second-generation drug-eluting stents: a network meta-analysis.

  2019cites this paper
• Silent Brain Infarcts Following Cardiac Procedures: A Systematic Review and Meta‐Analysis

  2019cites this paper
• Predialysis coronary revascularization and postdialysis mortality

  2019cites this paper
• Long‐term outcome in patients treated with first‐ versus second‐generation drug‐eluting stents for the treatment of unprotected left main coronary artery stenosis

  2019influential citation
• Percutaneous Coronary Intervention Versus Surgery in Left Main Stenosis-A Meta-Analysis and Systematic Review of Randomised Controlled Trials.

  2018cites this paper
• Interventional Therapy of Left Main Coronary Artery Disease

  2018cites this paper
• Ulembe study: Unprotected left main PCI study at 3 years follow up

  2018cites this paper
• Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study.

  2018cites this paper
• Safety and Effectiveness of Second-Generation Drug-Eluting Stents in Patients With Left Main Coronary Artery Disease.

  2018cites this paper
• Percutaneous coronary intervention in left main disease: SYNTAX, PRECOMBAT, EXCEL and NOBLE-combined cardiology and cardiac surgery perspective.

  2018cites this paper
• Ten-Year Outcomes of Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease

  2018cites this paper
• 10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease.

  2018cites this paper
• 10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left€Main€Coronary€Artery Disease

  2018cites this paper
• Left Main Disease: What Is the Correct Approach to Revascularization?

  2018cites this paper
• Role of Second-Generation Drug-Eluting Stents and Bypass Grafting in Coronary Artery Disease: A Systematic Review and Meta-analysis

  2017cites this paper
• Current Interventions for the Left Main Bifurcation.

  2017cites this paper
• PCI or CABG for severe unprotected left main coronary artery disease: making sense of the NOBLE and EXCEL trials.

  2017cites this paper
• Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main true bifurcation lesions

  2017cites this paper
• Through rose-colored glasses: Bringing focus back to revascularization.

  2017cites this paper
• Outcomes of Coronary Artery Bypass and Stents for Unprotected Left Main Coronary Stenosis.

  2017cites this paper
• Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial.

  2017cites this paper
• DIRETRIZ DA SOCIEDADE BRASILEIRA DE CARDIOLOGIA E DA SOCIEDADE BRASILEIRA DE HEMODINÂMICA E CARDIOLOGIA INTERVENCIONISTA SOBRE INTERVENÇÃO CORONÁRIA PERCUTÂNEA

  2017cites this paper
• Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era

  2017cites this paper
• Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.

  2017cites this paper
• Long‐term outcomes following mini‐crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New‐Tokyo (MITO) registry

  2017cites this paper
• Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry).

  2017cites this paper
• Unprotected Left Main Disease: Indications and Optimal Strategies for Percutaneous Intervention

  2016cites this paper
• Unprotected left main intervention for surgery-ineligible patients with coronary artery disease-Usefulness of micro-CT images for stent.

  2016cites this paper
• [Percutaneous coronary intervention of unprotected left main coronary compared with coronary artery bypass grafting; 3 years of experience in the National Institute of Cardiology, Mexico].

  2016cites this paper
• Adverse Cardiovascular Outcomes associated with Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention with Everolimus Eluting Stents: A Meta-Analysis

  2016cites this paper
• Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European Bifurcation Club.

  2016cites this paper
• Optical coherence tomography assessment of in-stent restenosis after percutaneous coronary intervention with two-stent technique in unprotected left main.

  2016cites this paper
• Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease.

  2016cites this paper
• Long-term survival among patients with coronary angioplasty with drug eluting stent for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting.

  2016cites this paper
• Left Main Percutaneous Coronary Intervention.

  2016cites this paper
• No More Debate Over Left Main Stenting Versus Bypass Surgery.

  2016cites this paper
• Update on Interventional Cardiology

  2016cites this paper
• Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes.

  2016cites this paper
• Update on percutaneous intervention for left main coronary artery stenosis

  2015cites this paper
• Coronary Revascularization for Patients with Severe Coronary Artery Disease:An Overview of Current Evidence and Treatment Strategies

  2015cites this paper
• Left main coronary artery disease: importance, diagnosis, assessment, and management.

  2015cites this paper
• Comparison of the first- and second-generation limus-eluting stents for bifurcation lesions from a Korean multicenter registry.

  2015cites this paper
• Left main PCI: An observational analysis from large single-centre experience

  2015cites this paper
• Percutaneous Coronary Intervention for Left Main Coronary Artery Disease - A Single Hospital Experience without On-Site Cardiac Surgery.

  2015cites this paper
• Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.

  2015cites this paper
• Current application and bioavailability of drug-eluting stents

  2014cites this paper
• Safety and Efficacy of Second-Generation Everolimus-Eluting Stents

  2014cites this paper
• Resultados a largo plazo del stent farmacoactivo de zotarolimus según sus indicaciones de uso (aprobadas versus no aprobadas)

  2014cites this paper
• Drug-eluting stents in unprotected left main coronary artery disease

  2014cites this paper
• Immediate results and long-term clinical outcome of patients with unprotected distal left main restenosis: the CORPAL registry (Córdoba and Las Palmas).

  2014cites this paper
• Surgical Versus Percutaneous Revascularization in Patients with Multivessel Coronary Artery Disease

  2014cites this paper
• Review: Outcomes of Revascularization Strategies for Coronary Artery Disease

  2014cites this paper
• Relationship between hyporesponsiveness to clopidogrel measured by thrombelastography and in stent restenosis in patients undergoing percutaneous coronary intervention.

  2014cites this paper
• Update on interventional cardiology.

  2013cites this paper
• Zabiegi stentowania niezabezpieczonego pnia lewej tętnicy wieńcowej w świetle aktualnych wytycznych i dowodów z badań randomizowanych Stentig of unprotected left main coronary artery in view of current guidelines and randomized clinical trials

  2013cites this paper
• Meta-analysis of everolimus-eluting stents versus first-generation drug-eluting stents in patients with left main coronary artery undergoing percutaneous coronary intervention.

  2013influential citation
• Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease.

  2013cites this paper
• Intervenção percutânea em lesão de tronco de coronária esquerda não protegido

  2013cites this paper
• Alice in Wonderland of drug-eluting stent for unprotected left main disease.

  2013cites this paper
• Percutaneous treatment of de novo unprotected left main stenosis in unselected consecutive patients: Experience of a high volume center

  2013cites this paper
• Percutaneous coronary intervention for unprotected left main coronary artery lesions

  2013cites this paper
• New-generation drug-eluting stent experience in the percutaneous treatment of unprotected left main coronary artery disease: the NEST registry.

  2013cites this paper
• [Update in interventional cardiology].

  2013cites this paper
• Is percutaneous coronary intervention as effective as bypass surgery in left main stem coronary artery stenosis?

  2013cites this paper
• Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.

  2013cites this paper
• Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.

  2013cites this paper
• [Update on interventional cardiology].

  2012cites this paper
• Coronary Stent Thrombosis: Current Insights into New Drug-Eluting Stent Designs

  2012cites this paper
• Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: from BARI to SYNTAX.

  2011cites this paper
• Update in interventional cardiology

  2011cites this paper
• Randomized trial of stents versus bypass surgery for left main coronary artery disease.

  2011cites this paper